UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Involvement of CRAF1, a Relative of TRAF, in CD40 Signaling

Science (American Association for the Advancement of Science), 1995-03, Vol.267 (5203), p.1494-1498

1995

Volltextzugriff (PDF)

A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor (BTKi) Zanubrutinib in Patients with Waldenström Macroglobulinemia (WM)

Blood, 2023-11, Vol.142 (Supplement 1), p.6171-6171

2023

Volltextzugriff (PDF)

Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group

British journal of haematology, 2013-07, Vol.162 (2), p.250-262

2013

Volltextzugriff (PDF)

Development of Hypertension and Atrial Fibrillation Following Diagnosis of B-Cell Malignancies - a Retrospective Analysis of US Marketscan Insurance Claims Database

Blood, 2022-11, Vol.140 (Supplement 1), p.12377-12378

2022

Volltextzugriff (PDF)

Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Receiving Ibrutinib on the Phase 3 ASPEN Study ≥1 Year After Transitioning to Zanubrutinib

Blood, 2023-11, Vol.142 (Supplement 1), p.3043-3043

2023

Volltextzugriff (PDF)

Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study

Blood, 2023-11, Vol.142 (Supplement 1), p.1890-1890

2023

Volltextzugriff (PDF)

Broad Superiority of Zanubrutinib (Zanu) Over Bendamustine + Rituximab (BR) Across Multiple High-Risk Factors: Biomarker Subgroup Analysis in the Phase 3 SEQUOIA Study in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) without del(17p)

Blood, 2023-11, Vol.142 (Supplement 1), p.1902-1902

2023

Volltextzugriff (PDF)

Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Blood, 2023-11, Vol.142 (Supplement 1), p.4655-4655

2023

Volltextzugriff (PDF)

Genomic Landscape of Ibrutinib- and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study

Blood, 2023-11, Vol.142 (Supplement 1), p.6510-6510

2023

Volltextzugriff (PDF)

A T Cell-specific Enhancer of the Human CD40 Ligand Gene

The Journal of biological chemistry, 2002-03, Vol.277 (9), p.7386-7395

2002

Volltextzugriff (PDF)

Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries

Medicine (Baltimore), 2010-11, Vol.89 (6), p.381-402

2010

Volltextzugriff (PDF)

Revisiting Human IL-12R beta 1 Deficiency A Survey of 141 Patients From 30 Countries

Medicine (Baltimore), 2010-11, Vol.89 (6), p.381-402

2010

Volltextzugriff (PDF)

Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation

International immunology, 2003-12, Vol.15 (12), p.1461-1472

2003

Volltextzugriff (PDF)

Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency: Medical and Immunological Implications

The Journal of experimental medicine, 2003-02, Vol.197 (4), p.527-535

2003

Volltextzugriff (PDF)

Cost Burden Analysis of Ineffective Induction Chemotherapy in Elderly Patients with AML

Blood, 2009-11, Vol.114 (22), p.4531-4531

2009

Volltextzugriff (PDF)

Single Cell Network Profiling (SCNP) Reveals Age-and Disease-Based Heterogeneity in Healthy Individuals and in Patients with Low Risk (LR) Myelodysplastic Syndrome (MDS)

Blood, 2011-11, Vol.118 (21), p.2788-2788

2011

Volltextzugriff (PDF)

Impaired Accumulation and Function of Memory CD4 T Cells in Human IL-12 Receptor β1 Deficiency

The Journal of immunology (1950), 2003-01, Vol.170 (1), p.597-603

2003

Volltextzugriff (PDF)

Single Cell Network Profiling (SCNP)-Based Classifier to Predict Response to Induction Therapy in Pediatric Patients with De Novo Acute Myeloid Leukemia (AML): Validation Study Results

Blood, 2011-11, Vol.118 (21), p.3544-3544

2011

Volltextzugriff (PDF)

Single Cell Network Profiling as a Tool to Identify AML Chemotherapy Resistant Cell Phenotypes Under In Vivo Therapeutic Pressure

Blood, 2009-11, Vol.114 (22), p.397-397

2009

Volltextzugriff (PDF)

The Role of IL-12 and IL-23 in the Generation and Maintenance of Memory CD4+ T Cells

Blood, 2004-11, Vol.104 (11), p.2664-2664

2004

Volltextzugriff (PDF)

Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency

The Journal of immunology (1950), 2003-01, Vol.170 (1), p.597-603

2003

Volltextzugriff (PDF)

The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes

Current opinion in hematology, 1996-01, Vol.3 (1), p.77-86

1996

Volltextzugriff (PDF)

FLT3 ITD Signaling Profiles in AML Samples Harboring Mutations

Blood, 2009-11, Vol.114 (22), p.1588-1588

2009

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Englisch
(54)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Immunology
(9)
Biological And Medical Sciences
(6)
Child
(6)
Animals
(5)
B-Lymphocytes - Immunology
(5)
Cd40 Ligand
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Male
(5)
Molecular Sequence Data
(5)
Adolescent
(4)
Adult
(4)
Base Sequence
(4)
Biochemistry & Molecular Biology
(4)
Cell Differentiation
(4)
Child, Preschool
(4)
Female
(4)
Fundamental Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Involvement of CRAF1, a Relative of TRAF, in CD40 Signaling

A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor (BTKi) Zanubrutinib in Patients with Waldenström Macroglobulinemia (WM)

Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group

Development of Hypertension and Atrial Fibrillation Following Diagnosis of B-Cell Malignancies - a Retrospective Analysis of US Marketscan Insurance Claims Database

Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Receiving Ibrutinib on the Phase 3 ASPEN Study ≥1 Year After Transitioning to Zanubrutinib

Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study

Broad Superiority of Zanubrutinib (Zanu) Over Bendamustine + Rituximab (BR) Across Multiple High-Risk Factors: Biomarker Subgroup Analysis in the Phase 3 SEQUOIA Study in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) without del(17p)

Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R/R CLL/SLL: Final Comparative Analysis of ALPINE

Genomic Landscape of Ibrutinib- and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study

A T Cell-specific Enhancer of the Human CD40 Ligand Gene

Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries

Revisiting Human IL-12R beta 1 Deficiency A Survey of 141 Patients From 30 Countries

Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-Free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL)

Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation

Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency: Medical and Immunological Implications

Cost Burden Analysis of Ineffective Induction Chemotherapy in Elderly Patients with AML

Single Cell Network Profiling (SCNP) Reveals Age-and Disease-Based Heterogeneity in Healthy Individuals and in Patients with Low Risk (LR) Myelodysplastic Syndrome (MDS)

Impaired Accumulation and Function of Memory CD4 T Cells in Human IL-12 Receptor β1 Deficiency

Single Cell Network Profiling (SCNP)-Based Classifier to Predict Response to Induction Therapy in Pediatric Patients with De Novo Acute Myeloid Leukemia (AML): Validation Study Results

Single Cell Network Profiling as a Tool to Identify AML Chemotherapy Resistant Cell Phenotypes Under In Vivo Therapeutic Pressure

The Role of IL-12 and IL-23 in the Generation and Maintenance of Memory CD4+ T Cells

Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency

The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes

FLT3 ITD Signaling Profiles in AML Samples Harboring Mutations

Suchergebnisse filtern